Synuclein-γ (SNCG) protein expression is associated with poor outcome in endometrial adenocarcinoma. - Wikidata - wikimedia - TriplyDB

Synuclein-γ (SNCG) protein expression is associated with poor outcome in endometrial adenocarcinoma.

Synuclein-γ (SNCG) protein expression is associated with poor outcome in endometrial adenocarcinoma.

http://www.wikidata.org/entity/Q37305478

about

Combining affinity propagation clustering and mutual information network to investigate key genes in fibroid.Alternative splicing of synuclein gamma in endometrial cancer: identification of a novel isoform.Synuclein-γ (SNCG) expression in ovarian cancer is associated with high-risk clinicopathologic disease.Loss of caveolin-1 in prostate cancer stroma correlates with reduced relapse-free survival and is functionally relevant to tumour progression.Prognostic biomarkers in endometrial and ovarian carcinoma.Synuclein-γ in uterine serous carcinoma impacts survival: An NRG Oncology/Gynecologic Oncology Group study.A transcriptome-based protein network that identifies new therapeutic targets in colorectal cancer.An exploratory analysis of γ-synuclein expression in endometrioid endometrial cancer.Clinical study of the relationship between γ-synuclein and the response of neoadjuvant chemotherapy in breast cancer.

P2860

Q33846544-6C95D7B8-4EE8-489B-B49D-6EBE3776CC9F Q36356015-4DBB01D2-C021-49A5-84F9-173FE3DA68B0 Q37391092-5AA9FDCB-A56D-4E82-B7BC-6BE77D4C804B Q37690429-819A9204-50B7-42D4-BD28-3853727DD051 Q38185940-56A331CE-1B2C-4D69-B601-42CE5D4656B7 Q39123683-29523CB4-E511-46E7-8290-64F834E55FCF Q41949320-342D1C63-0DFE-4B85-854E-4F8AA7822F85 Q42143433-87CDA561-C816-4B46-836C-C87EC4425A6B Q44700598-0E9F63BC-7230-4D8D-80A2-01C4FBA11012

P2860

Synuclein-γ (SNCG) protein expression is associated with poor outcome in endometrial adenocarcinoma.

http://www.wikidata.org/entity/Q37305478

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 19 October 2011

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Synuclein-γ (SNCG) protein exp ...... in endometrial adenocarcinoma.

@en

Synuclein-γ

@nl

type

label

Synuclein-γ (SNCG) protein exp ...... in endometrial adenocarcinoma.

@en

Synuclein-γ

@nl

prefLabel

Synuclein-γ (SNCG) protein exp ...... in endometrial adenocarcinoma.

@en

Synuclein-γ

@nl

P1433

Q37305478-DBEDAF07-5650-4889-A5A9-4A0BD7E7B8A7

P1476

Q37305478-FEBE0788-38CE-4E61-B14F-7AE242D1C817

P2093

Q37305478-5F672271-7727-4749-8ADF-E9ADE1620AEA

Q37305478-60169BBB-0F96-4C9D-BEFB-D9A39D07DAB3

Q37305478-7AB283A4-450E-4AC4-96AA-26A0B759580C

Q37305478-8E03846D-F28C-4981-BEC6-21B13DBF849F

Q37305478-9C6F7B93-AE27-4729-A501-4B634CE6AACD

Q37305478-AD03E396-3320-42E7-BF79-5F3765F07E9D

P2860

Q37305478-0B560FA5-2448-479F-8497-2875E2401AB9

Q37305478-10DEE3CA-DD58-4C3F-B9AA-A327BFD719B4

Q37305478-1491597C-DD58-45A8-AAE9-DC434ECA676E

Q37305478-1DD191CF-369F-455C-9D60-7064723C7736

Q37305478-2088A11B-8DB6-4C87-873B-64F8F7B2CD7D

Q37305478-29021ED6-04DF-496C-B044-07F40923D6A5

Q37305478-2F200A2D-3924-471F-A222-844ADE7B81E3

Q37305478-314C509E-7369-435F-B2CD-A1ABB0699E61

Q37305478-3A66F0BE-2AB7-4249-B0B2-C969353200BF

Q37305478-409186D2-CCFE-4DE0-9C4B-B4DBA26112E0

P304

Q37305478-162A1A04-12D2-47F1-816F-B23D56752AFD

P31

Q37305478-20730D69-740E-49AB-8F37-F5773EF59BF9

P356

Q37305478-94163D0A-19B7-4E19-AE49-C6E932CFB6B8

P407

Q37305478-283F621C-E5D7-4678-BDB2-B02D83B6177E

P433

Q37305478-E3AD38E9-AC5C-4148-924C-A27B6D7C34B4

P478

Q37305478-0C9D4A81-28BD-4D5E-9632-E2CF86711F17

P50

Q37305478-9569A75B-6DDF-41CD-9080-2175EE1894E6

P577

Q37305478-E20D4B8C-7E3E-4A80-ABED-0B56CBCCC6B3

P698

Q37305478-AA5BE812-A81A-46D1-B14C-15A3B882C9DA

P921

Q37305478-4109BE17-285C-449A-B216-136113E44834

Q37305478-624A6BE1-2492-41E8-87AC-3A08921E9C00

P932

Q37305478-D1D80236-EA5A-4B4D-A8D6-358045BB1049

P356

J.YGYNO.2011.09.037

P1433

Gynecologic Oncology

P1476

Synuclein-γ (SNCG) protein exp ...... in endometrial adenocarcinoma.

@en

P2093

Dan Wang

http://www.w3.org/2001/XMLSchema#string

Heidi Godoy

http://www.w3.org/2001/XMLSchema#string

Nefertiti Dupont

http://www.w3.org/2001/XMLSchema#string

Paulette Mhawech-Fauceglia

http://www.w3.org/2001/XMLSchema#string

Song Liu

http://www.w3.org/2001/XMLSchema#string

Susanna Syriac

http://www.w3.org/2001/XMLSchema#string

P2860

Synucleins are expressed in the majority of breast and ovarian carcinomas and in preneoplastic lesions of the ovary

Identification of a breast cancer-specific gene, BCSG1, by direct differential cDNA sequencing

Cancer statistics, 2009

Gamma-synuclein promotes cancer cell survival and inhibits stress- and chemotherapy drug-induced apoptosis by modulating MAPK pathways.

Gene expression profiles in stage I uterine serous carcinoma in comparison to grade 3 and grade 1 stage I endometrioid adenocarcinoma.

G(1) and G(2) cell-cycle arrest following microtubule depolymerization in human breast cancer cells.

Prognostic parameters of endometrial carcinoma.

Gamma-synuclein and the progression of cancer.

Novel molecular profiles of endometrial cancer-new light through old windows.

Uterine papillary serous carcinoma: state of the state.

P304

148-152

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.YGYNO.2011.09.037

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

124

http://www.w3.org/2001/XMLSchema#string

P50

P577

2011-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22015044

http://www.w3.org/2001/XMLSchema#string

P921

P932

5047382

http://www.w3.org/2001/XMLSchema#string